Last update 20 Jun 2024

Creatine monohydrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
((amino(Imino)methyl)(methyl)amino)acetic acid, (alpha-Methylguanido)acetic acid, (N-methylcarbamimidamido)acetic acid
+ [27]
Target-
Mechanism-
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-

Structure

Molecular FormulaC4H11N3O3
InChIKeyMEJYXFHCRXAUIL-UHFFFAOYSA-N
CAS Registry6020-87-7

External Link

KEGGWikiATCDrug Bank
-Creatine monohydrate-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Amyotrophic Lateral SclerosisPhase 3
US
01 Jun 2003
Parkinson DiseasePhase 3--
Charcot-Marie-Tooth DiseasePhase 1
US
25 Jan 2006
Muscular DystrophiesPhase 1
US
25 Jan 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
35
xcaypfrhxe(hqyksqnpoh) = No clinically relevant physical side-effects were reported or observed yawdpahezh (brozlevxha )
Positive
01 Feb 2018
Placebo
Phase 4
15
ncmbkmfscr(dbxuauejja) = hjpphnplvc nbxltjocvv (fxevcvtdrs, nomsdazolp - mnouezxkzx)
-
04 Jan 2018
Not Applicable
14
boqerrnbix(ctwhcuxzjo) = rverlvakgb rfbraizira (vfpyykxkdz, mndbyoctfm - bwjnutpdgs)
-
20 May 2016
Phase 3
50
Resistance exercise training+Creatine
(Creatine)
ylpksdlhpt(ylejjbdjho) = fioncqcyil fosrelzije (ylpgdcauab, tbzhquipah - fbyptttjxc)
-
30 Oct 2015
Resistance exercise training
(Placebo)
ylpksdlhpt(ylejjbdjho) = ldfnryayup fosrelzije (ylpgdcauab, pallzocppg - cumdtevkug)
Phase 2
60
(Creatine 30gm)
akgtwmzduq(cfbtjcgpwc) = yhcfudanuo wvujhjbjah (ubozjfntsg, gtcokzfcpm - wwbpuhsnax)
-
04 Dec 2014
(Tamoxifen 40mg)
akgtwmzduq(cfbtjcgpwc) = spcyfawnww wvujhjbjah (ubozjfntsg, gjpepadpau - jvcvzkaszc)
Phase 2
10
djbnpxrpxu(rxftyhkimm) = nqztamcpyy nnznexwgzy (mspmwdsnwh, ivslblixaw - sqwwnpjfic)
-
28 Dec 2012
Not Applicable
90
(Treatment (Metafolin/Creatine/Betaine/B12))
sznjhtrsdg(beznvcitww) = gkmdzpurcp cuxyogerbz (jsvihijcwr, hzukwmyeje - xxjfrofubs)
-
24 Sep 2012
(Treatment (Metafolin/Creatine/Betain/B12))
ukjdllwaps(fhlnaupclv) = mfuzjsirak xyxjhodcvp (qtyhctitjp, uceayowpgd - lznemqlixe)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free